Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1133 | 1134 | (Page 1135) | 1136 | 1137 | .... | 1146 | newer

    0 0

    (EMAILWIRE.COM, January 05, 2019 ) The global Gel Electrophoresis Market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.

    Gel electrophoresis is a method for separation and analysis of macromolecules (DNA, RNA and proteins) and their fragments, based on their size and charge. It is used in clinical chemistry to separate proteins by charge and/or size (IEF agarose, essentially size independent) and in biochemistry and molecular biology to separate a mixed population of DNA and RNA fragments by length, to estimate the size of DNA and RNA fragments or to separate proteins by charge.

    Global Gel Electrophoresis Market Report including definitions, classifications, applications and industry chain structure. Global Gel Electrophoresis Market status, size, outlook of global and major regions, from angles of manufacturers, regions, product types and end industries.

    Complete report on Gel Electrophoresis Market spread across 119 pages, profiling 14 companies and supported with tables and figures is now available @ https://www.reportsnreports.com/contacts/discount.aspx?name=1835334

    The various contributors involved in the value chain of Gel Electrophoresis include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Gel Electrophoresis include - Agilent Technologies,Bio-Rad Laboratories,Thermo Fisher Scientific,C.B.S. Scientific,Harvard Bioscience, Helena Laboratories,Hoefer,Lonza,Sysmex Partec , PerkinElmer, Sebia, SERVA Electrophoresis,Sigma-Aldrich And Shimadzu

    Gel Electrophoresis Breakdown Data by Type
    - Agarose Gel
    - Pulse Field Gel
    - Temperature Gradient Gel

    Gel Electrophoresis Breakdown Data by Application
    - Laboratory Research
    - Pharmaceutical and Biotechnological Companies

    This report presents the worldwide Gel Electrophoresis Market size (value, production and consumption), splits the breakdown (data status 2014-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

    The report focuses on global major leading industry players of Gel Electrophoresis Market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Gel Electrophoresis Market development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

    Order a copy of Global Gel Electrophoresis Market Report 2019 @ https://www.reportsnreports.com/purchase.aspx?name=1835334

    Personalized medicine is an umbrella term used for treatments tailor-made to suit individual patients’ anatomy and morphology. Personalized medicines greatly increase the efficacy of treatments through companion diagnostics and genetic testing. These drugs minimize any adverse effects the treatment may have on the patient. Gel electrophoresis techniques are widely adopted in the field of personal medicine to accurately map and analyze the abnormal tissues or molecules responsible for causing the illness. Electrophoresis techniques such as two-dimensional difference gel electrophoresis provide quantitative, sensitive, reproducible, high-throughput, and exhaustive global protein expression profiling.

    The global Gel Electrophoresis market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gel Electrophoresis market based on company, product type, end user and key regions. With tables and figures helping analyze worldwide Gel Electrophoresis Market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Major Points from Table of Contents
    Charpter 1 – Gel Electrophoresis Market Overview
    Charpter 2 – Global Gel Electrophoresis Competition by Players/Suppliers, Type and Application
    Charpter 3 – United States Gel Electrophoresis (Volume, Value and Sales Price)
    Charpter 4 – China Gel Electrophoresis (Volume, Value and Sales Price)
    Charpter 5- Europe Gel Electrophoresis (Volume, Value and Sales Price)
    Charpter 6 – Japan Gel Electrophoresis (Volume, Value and Sales Price)
    Charpter 7 – Southeast Asia Gel Electrophoresis (Volume, Value and Sales Price)
    Charpter 8 – India Gel Electrophoresis (Volume, Value and Sales Price)
    Charpter 9 – Global Gel Electrophoresis Players/Suppliers Profiles and Sales Data
    Charpter 10 – Gel Electrophoresis Maufacturing Cost Analysis
    Charpter 11 – Industrial Chain, Sourcing Strategy and Downstream Buyers
    Charpter 12 – Marketing Strategy Analysis, Distributors/Traders
    Charpter 13 – Market Effect Factors Analysis
    Charpter 14 – Global Gel Electrophoresis Market Forecast (2019-2025)
    Charpter 15 – Research Findings and Conclusion
    Charpter 16 – Appendix

    A discount can be asked before order a copy of Gel Electrophoresis Market report at https://www.reportsnreports.com/contacts/discount.aspx?name=1835334

    About Us:
    ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.



    Vishal Kalra
    + 18883915441
    sales@reportsandreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, January 05, 2019 ) The global Holter Monitors Market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.

    The report focuses on global major leading industry players of Holter Monitors Market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Holter Monitors Market development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

    A Holter monitor is a battery-operated device that measures and records the heart's activity constantly for 48-72 hours. The device contains electrodes that are attached to the skin. With the help of these electrodes, the ECG is measured constantly. The Holter monitor is used to monitor patients with slow, fast, or irregular heartbeat. It helps a doctor in deciding whether the patient requires a pacemaker or a cardiovascular procedure to restore regular heart rhythm. The monitor can help the doctors to check if the medicines are working and if the heart is getting enough oxygen to meet its needs. It can also help doctors determine the reason for a patient's dizziness or the feeling of the heart racing or skipping a beat.

    Complete report on Holter Monitors Market spread across 111 pages, profiling 13 companies and supported with tables and figures is now available @ https://www.reportsnreports.com/contacts/discount.aspx?name=1835501

    The various contributors involved in the value chain of Holter Monitors include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Holter Monitors include
    - Koninklijke Philips
    - GE Healthcare
    - Spacelabs Healthcare
    - Mortara Instrument
    - Applied Cardiac Systems
    - Borsam Medical
    - CardioNet
    - LifeWatch
    - LUMED
    - Medicomp
    - Nasiff Associates
    - QRS Diagnostic
    - Suzuken

    Holter Monitors Breakdown Data by Type
    - Holter Monitoring Devices
    - Event Monitoring Devices
    - Holter Monitoring Software

    Holter Monitors Breakdown Data by Application
    - Hospital
    - Physicians' Clinics
    - ASCs

    This report presents the worldwide Holter Monitors Market size (value, production and consumption), splits the breakdown (data status 2014-2018 and forecast to 2025).A large number of people suffer from several heart problems because they are unaware of high blood pressure as hypertension remains undetected at initial stages. This is increasing prevalence of heart stroke. As a result, the need for monitoring heartbeats at regular intervals increases. This will boost the sales volume of cardiac Holter monitor as they are extensively used to monitor heartbeat. Technavio’s market research report identifies that the rising demand for home-based monitoring?is one of the primary growth drivers for the global Holter monitors market till 2023. Portable Holter monitor can be used at home as they are easy to use, save time, reduce expenses, and reduce the burden on hospitals.

    Order a copy of Global Holter Monitors Market Report 2019 @ https://www.reportsnreports.com/purchase.aspx?name=1835501

    The global Holter Monitors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Holter Monitors market based on company, product type, end user and key regions. With tables and figures helping analyze worldwide Holter Monitors Market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Major Points from Table of Contents
    Charpter 1 – Holter Monitors Market Overview
    Charpter 2 – Global Holter Monitors Competition by Players/Suppliers, Type and Application
    Charpter 3 – United States Holter Monitors (Volume, Value and Sales Price)
    Charpter 4 – China Holter Monitors (Volume, Value and Sales Price)
    Charpter 5- Europe Holter Monitors (Volume, Value and Sales Price)
    Charpter 6 – Japan Holter Monitors (Volume, Value and Sales Price)
    Charpter 7 – Southeast Asia Holter Monitors (Volume, Value and Sales Price)
    Charpter 8 – India Holter Monitors (Volume, Value and Sales Price)
    Charpter 9 – Global Holter Monitors Players/Suppliers Profiles and Sales Data
    Charpter 10 – Holter Monitors Maufacturing Cost Analysis
    Charpter 11 – Industrial Chain, Sourcing Strategy and Downstream Buyers
    Charpter 12 – Marketing Strategy Analysis, Distributors/Traders
    Charpter 13 – Market Effect Factors Analysis
    Charpter 14 – Global Holter Monitors Market Forecast (2019-2025)
    Charpter 15 – Research Findings and Conclusion
    Charpter 16 – Appendix

    A discount can be asked before order a copy of Holter Monitors Market report at https://www.reportsnreports.com/contacts/discount.aspx?name=1835501

    About Us:
    ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.



    Vishal Kalra
    + 18883915441
    sales@reportsandreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, January 05, 2019 ) The global Hemodialysis Catheters Market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.

    This report presents the worldwide Hemodialysis Catheters Market size (value, production and consumption), splits the breakdown (data status 2014-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

    Complete report on Hemodialysis Catheters Market spread across 110 pages, profiling 09 companies and supported with tables and figures is now available @ https://www.reportsnreports.com/contacts/discount.aspx?name=1835437

    The various contributors involved in the value chain of Hemodialysis Catheters include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Hemodialysis Catheters include – - AngioDynamics, C.R. Bard,Fresenius Medical Care, Medical Components, Medtronic, Argon Medical Devices, Cook Medical, Foshan Special Medical And Navilyst Medical.

    Hemodialysis Catheters Breakdown Data by Type
    - Long-Term Hemodialysis Catheters
    - Short-Term Hemodialysis Catheters

    Hemodialysis Catheters Breakdown Data by Application
    - Home Dialysis
    - In-Center Dialysis

    Hemodialysis is a life-saving intervention for patients with end-stage renal disease (ESRD). Patients with renal disease are affected by progressive loss in the liver functioning. It eventually becomes necessary for the patient to opt for dialysis treatment to sustain healthy life. ESRD is generally the end stage of chronic kidney disease (CKD), which has high prevalence worldwide. Hemodialysis is an alternative for numerous vital functions of kidneys. The dialysis machine itself is termed to be as an artificial kidney. It is generally used for removal of excess content of water and waste products or impurities from kidneys to filter patient’s blood when kidneys are damaged or dysfunctional. The dialysis machine brings about filtration of blood using a dialyzer, while removal of the blood (containing impurities or waste products) and returning of the filtered blood to the patient is brought about by surgical vascular access.

    Order a copy of Global Hemodialysis Catheters Market Report 2019 @ https://www.reportsnreports.com/purchase.aspx?name=1835437

    The report focuses on global major leading industry players of Hemodialysis Catheters Market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Hemodialysis Catheters Market development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

    The global Hemodialysis Catheters market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hemodialysis Catheters market based on company, product type, end user and key regions. With tables and figures helping analyze worldwide Hemodialysis Catheters Market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Major Points from Table of Contents
    Charpter 1 – Hemodialysis Catheters Market Overview
    Charpter 2 – Global Hemodialysis Catheters Competition by Players/Suppliers, Type and Application
    Charpter 3 – United States Hemodialysis Catheters (Volume, Value and Sales Price)
    Charpter 4 – China Hemodialysis Catheters (Volume, Value and Sales Price)
    Charpter 5- Europe Hemodialysis Catheters (Volume, Value and Sales Price)
    Charpter 6 – Japan Hemodialysis Catheters (Volume, Value and Sales Price)
    Charpter 7 – Southeast Asia Hemodialysis Catheters (Volume, Value and Sales Price)
    Charpter 8 – India Hemodialysis Catheters (Volume, Value and Sales Price)
    Charpter 9 – Global Hemodialysis Catheters Players/Suppliers Profiles and Sales Data
    Charpter 10 – Hemodialysis Catheters Maufacturing Cost Analysis
    Charpter 11 – Industrial Chain, Sourcing Strategy and Downstream Buyers
    Charpter 12 – Marketing Strategy Analysis, Distributors/Traders
    Charpter 13 – Market Effect Factors Analysis
    Charpter 14 – Global Hemodialysis Catheters Market Forecast (2019-2025)
    Charpter 15 – Research Findings and Conclusion
    Charpter 16 – Appendix

    A discount can be asked before order a copy of Hemodialysis Catheters Market report at https://www.reportsnreports.com/contacts/discount.aspx?name=1835437

    About Us:
    ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.



    Vishal Kalra
    + 18883915441
    sales@reportsandreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, January 06, 2019 ) Global Medical Ventilator Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Medical Ventilator. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Medical Ventilator market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Medical Ventilator Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-medical-ventilator-market-research-report-2018

    With this Medical Ventilator Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Resmed, Medtronic, Bd (Carefusion), Philips Healthcare, Ge Healthcare, Invacare, Teijin Pharma, Fisher & Paykel, Drager Medical, Devilbiss, Event Medical and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1010171

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Medical Ventilator Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1010171

    List of Chapters:
    1 Medical Ventilator Market Overview
    2 Global Medical Ventilator Market Competitions by Manufacturers
    3 Global Medical Ventilator Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Medical Ventilator Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Medical Ventilator Production, Revenue (Value), Price Trend by Type
    6 Global Medical Ventilator Market Analysis by Application
    7 Global Medical Ventilator Manufacturers Profiles/Analysis
    8 Medical Ventilator Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Medical Ventilator Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, January 06, 2019 ) Global Nucleic Acid Amplification Testing Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Nucleic Acid Amplification Testing. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Nucleic Acid Amplification Testing market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Nucleic Acid Amplification Testing Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-nucleic-acid-amplification-testing-market-research-report-2018

    With this Nucleic Acid Amplification Testing Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are F. Hoffmann-La Roche, Becton, Dickinson and Company, Beckman Coulter, Abbott Laboratories, Illumina, Siemens Healthineers, bioMerieux, Novartis, Bio-Rad Laboratories and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/853163

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Nucleic Acid Amplification Testing Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/853163

    List of Chapters:
    1 Nucleic Acid Amplification Testing Market Overview
    2 Global Nucleic Acid Amplification Testing Market Competitions by Manufacturers
    3 Global Nucleic Acid Amplification Testing Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Nucleic Acid Amplification Testing Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Nucleic Acid Amplification Testing Production, Revenue (Value), Price Trend by Type
    6 Global Nucleic Acid Amplification Testing Market Analysis by Application
    7 Global Nucleic Acid Amplification Testing Manufacturers Profiles/Analysis
    8 Nucleic Acid Amplification Testing Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Nucleic Acid Amplification Testing Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, January 06, 2019 ) Global Orthopaedic Implants Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Orthopaedic Implants. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Orthopaedic Implants market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Orthopaedic Implants Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-orthopaedic-implants-market-research-report-2018

    With this Orthopaedic Implants Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Zimmer Biomet, DePuy Synthes, Stryker, Smith & Nephew, Medtronic, NuVasive, Globus Medical, B. Braun Aesculap, Wright Medica, Acumed, MicroPort and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/930416

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Orthopaedic Implants Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/930416

    List of Chapters:
    1 Orthopaedic Implants Market Overview
    2 Global Orthopaedic Implants Market Competitions by Manufacturers
    3 Global Orthopaedic Implants Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Orthopaedic Implants Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Orthopaedic Implants Production, Revenue (Value), Price Trend by Type
    6 Global Orthopaedic Implants Market Analysis by Application
    7 Global Orthopaedic Implants Manufacturers Profiles/Analysis
    8 Orthopaedic Implants Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Orthopaedic Implants Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, January 06, 2019 ) Antigens, commonly, are referred to as substances that are capable of triggering an immune response in a host, precisely by activating the lymphocytes or initiating antibody production against the infection. Depending upon the fact that they either enter the human body or originate within the body, these fungal antigens are classified as foreign or self-antigens. Among these, the self-antigens comprise of mutated or overexpressed proteins. However, foreign antigens may include fungus, bacteria, parasites, viruses, chemicals, and sometimes toxins & proteins found in food products.

    A wide range of fungal species of Aspergillus and other fungal organisms play important roles in the pharmacy and healthcare industry. For instance, some of the Aspergillus species play vital roles in commercial microbial fermentations and are also involved in the production of foreign or native enzymes. These fungal species can cause infections in humans. A range of fungal diseases in humans include infections of the ear, external skin wounds and ulcers. Other fungal species also act as raw material sources that can be used to develop medications. Owing to increased applications of fungal antigens to diagnose various fungal infections for clinical research purposes, a large number of local manufacturers have expanded their product portfolio of fungal pathogens intended for academic as well as industrial applications.

    Fungal antigens in the fungal antigens market are commercially available in distinct formats, which include purified and inactivated pathogens. A wide range of native state fungal antigens are highly in demand, particularly for in-vitro diagnostics. Standard properties recommended for apt fungal antigens include higher specificity & sensitivity, simple production & quality control and the capability of a fungal antigen to carry out early diagnosis of fungal infection in order to get effective treatment. Under the product type segment defined for the fungal antigens market, the Aspergillus antigen accounts for a significant revenue share in the global fungal antigens market followed by the Saccharomyces fungal antigen. On the account of their usage as reagents to diagnose fungal diseases, fungal antigens are of great interest. These fungal antigens find applications in various diagnostic techniques, which include Immunohistochemistry (IHC), Polymerase chain reaction (PCR), In-situ hybridization (ISH) and SDS-PAGE in the fungal antigens market. They also find major applications to carry out immunological tests to diagnose mycotic infections. With the growing incidence of fungal diseases, there is an urgent need to create sensitive, commercially available and reliable tests to diagnose the opportunistic fungal pneumonias. The major potential end users for the fungal antigens market, where these antigens are highly in demand and generate significant revenues, include hospitals, associated diagnostic laboratories, diagnostic laboratories & centres and academic & research institutes.

    Request Report Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1773=

    Fungal Antigens Market: Drivers and Restraints

    The growing demand for fungal antigens indicated for fungal antigens that are capable of eliciting a protective immune response against various cancers and infectious diseases such as HIV AIDS is expected to be a major factor driving the fungal antigens market over the forecast period. Also, rapid discovery of novel fungal antigens, growing incidence of cancers & infectious diseases and increase in diagnostic population for variant diseases is also expected to drive the revenue growth of the global fungal antigens market. Also, increasing prevalence of infections caused by fungal pathogens and changing climatic conditions leading to increased incidence of fungal infections is expected to generate revenue opportunities for the fungal antigens market. The approval and launch of new fungal antigens is the other important factor contributing to the growth of the global fungal antigens market. However, increasing risk of adverse reactions with antigens is restraining the revenue growth of the global fungal antigens market.

    Fungal Antigens Market: Segmentation

    Tentatively, the global fungal antigens market can be segmented on the basis of product type, pathogen type, application, end user and geography.

    Based on product type, the global fungal antigens market is segmented as:

    Aspergillus Antigen
    aculeatus Pectolyase Y-23
    Aspergillus Giganteus AF Protein
    Aspergillus Restrictus Restrictocin
    Aspergillus Giganteus Alpha-Sarcin
    Aspergillus fumigatus Antigen
    Candida albicans Antigen
    Saccharomyces Antigen
    A. caninum NIF
    S. pombe RNA1P
    S. pombe RNA

    Based on pathogen type, the global fungal antigens market is segmented as:

    Inactivated Pathogen
    Purified Pathogen

    Based on application type, the global fungal antigens market is segmented as:

    Immunohistochemistry (IHC)
    Polymerase chain reaction (PCR)
    In-situ hybridization(ISH)
    SDS-PAGE

    Based on end user, the global fungal antigens market is segmented as:

    Hospital Associated Diagnostic Laboratories
    Diagnostic Laboratories and Centres
    Academic and Research Institutes

    Fungal Antigens Market: Overview

    The global market for fungal antigens is expected to register a moderate growth rate over the forecast period owing to significant investments to introduce innovative tests to capitalise on the opportunities in the untapped market. According to a study conducted by CDC, histoplasmosis is registered as significant infection in patients with HIV and AIDS. Late diagnosis leading to the delayed treatment of the disease can prove fatal, hence, the need for fungal antigens is on rise. Recently, different types of fungal antigens are being introduced in the fungal antigens market by the leading players, which include Bio-Rad Laboratories, Inc. and Creative Diagnostics. There is high competition among local and regional players in the fungal antigens market. Among the fungal antigens type indicated for various diagnostic applications, the Aspergillus antigen segment is expected to lead the global fungal antigens market over the forecast period. Diagnostic laboratories and centres are expected to contribute a high revenue share in the global fungal antigens market as they are the most significant platforms to perform diagnostic tests and generate high demand for fungal antigens. Hospital-associated diagnostic laboratories also account for significant revenue generation owing to a large number of patients wanting to get diagnosed.

    Request for Brochure @ https://www.factmr.com/connectus/sample?flag=B&rep_id=1773

    Fungal Antigens Market: Regional Outlook

    Geographically, the global fungal antigens market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific Excluding Japan, Japan and the Middle East & Africa. North America is registered as the dominant market player in global fungal antigens market on the account of growing research applications of fungal antigens along with increased set up of advanced diagnostic laboratories in the region as compared to other regions. The fungal antigens market in Asia Pacific excluding Japan is expected to grow at the highest CAGR due to a strong foothold of domestic players manufacturing fungal antigens. Europe is expected to register the second largest revenue share in the global fungal antigens-market throughout the forecast period owing to the increased presence of distributors and suppliers for fungal antigens across the region.

    Fungal Antigens Market: Key Players

    The global fungal antigens market is highly fragmented owing to presence of a large number of domestic manufacturers. Examples of some of the key players operating in the global fungal antigens market are Bio-Rad Laboratories, Inc., Creative Diagnostics, IMMY, QED Bioscience Inc., Pulse Scientific Inc. and Jena Bioscience GmbH.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    Request TOC of this Report @ https://www.factmr.com/connectus/sample?flag=T&rep_id=1773



    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, January 06, 2019 ) Wireless pH monitoring systems also known as catheter-free pH monitoring systems. pH monitoring is a procedure used for measuring and monitoring the acidity or alkalinity of gastric reflux. It is likely to be used for Gastroesophageal Reflux Disease (GERD) and provides information about the symptoms and causes of the disease. Traditional pH monitoring systems are inconvenient, uncomfortable and interfere in the normal activities, which is likely to affect the result. In traditional pH monitoring systems, a catheter is used to monitor the pH of the stomach.

    It is passed trans-nasally into the oesophagus of the patient. An alternative device to traditional pH monitoring systems, i.e. a catheter-free wireless pH monitoring system, has been introduced, which is convenient to use, easy to handle and does not interfere with the body’s activities. During an endoscopy, the wireless pH monitoring system monitors and records the information of the stomach and oesophagus track through a small pH capsule that is attached temporarily to the wall of the oesophagus, following which the pH records are noted and transmitted to a receiver. These advantages of wireless pH monitoring systems over traditional pH monitoring systems increases the demand for wireless pH monitoring systems.

    Wireless pH Monitoring Systems Market: Drivers and Restraints

    With wireless pH monitoring systems, patients can perform their daily activities as they improve the tolerance rate of patients. Wireless pH monitoring systems use radiotelemetry that senses the pH and transmits the signal to the receiver. Wireless pH monitoring systems are more capable of increasing the recording periods as compared to traditional pH monitoring systems. These factors are driving the Wireless pH Monitoring Systems Market. However, there is a possibility of the overestimation of records collected through wireless pH monitoring systems because these systems cannot distinguish acid swallow from acid reflux. Moreover, short reflux episodes cannot be recorded due to low sampling rate. Patients with functional disorders are likely to experience chest pain and discomfort due to the placement of a pH capsule in the oesophagus wall due to which it needs to be removed. This can affect the recording performed by the capsule. In addition, the cost of wireless pH monitoring systems is high as compared to traditional pH monitoring systems. These factors are likely to retrain the wireless pH monitoring systems market.

    Request Report Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1772

    Wireless pH Monitoring Systems Market: Segmentation

    The global wireless pH monitoring systems market can be segmented on the basis of therapeutic drug type and end user.

    Based on therapeutic drug type, the global Wireless pH Monitoring Systems market is segmented as:

    Antacids
    Proton Pump Inhibitors (PPIs)
    H2 Receptor Blockers
    Prokinetics
    Others

    Based on end user, the global Wireless pH Monitoring Systems market is segmented as:

    Hospitals
    Ambulatory Surgical Centres
    Others

    Wireless pH Monitoring Systems Market: Overview

    The global market of wireless pH monitoring systems is expected to register steady growth as traditional pH monitoring systems are still being used in several mid- and low-income countries to monitor the acid reflux of the stomach and oesophagus tract due high cost and unavailability of the system in these regions. However, the advantages of wireless pH monitoring systems, which include improved tolerance rate, easy & convenient usage and non-interference in the daily activities of patients, over the traditional pH monitoring systems are expected to boost the global wireless pH monitoring market during the forecast period.

    Request for Brochure @ https://www.factmr.com/connectus/sample?flag=B&rep_id=1772

    Wireless pH Monitoring Systems Market: Regional Outlook

    Geographically, the Wireless pH Monitoring Systems market is segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the dominant market in the global wireless pH monitoring systems market followed by Europe due to the presence of improved healthcare infrastructure, awareness about medical insurance coverage, favourable reimbursement policies, advanced assessment & expenditure and a rapidly growing economy. The Asia Pacific excluding Japan region is expected to grow at a significant CAGR during the forecast period.

    Wireless pH Monitoring Systems Market: Key Players

    Examples of some of the key players operating in the global wireless pH monitoring system market are Medtronic and Wellmark, Inc.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    Request TOC of this Report @ https://www.factmr.com/connectus/sample?flag=T&rep_id=1772





    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, January 09, 2019 ) Drug eluting balloon catheter is an advanced medical device which has shown remarkable efficiency in carrying out various peripheral artery and cardiovascular procedures. A large number of companies are now shifting towards manufacturing of drug eluting balloon catheters as they are proving to be more efficient as compared to stenting or balloon angioplasty. In addition, drug eluting balloon catheter can also help in treating patients who do not benefit from percutaneous coronary intervention (PCI). Factors as such are expected to favour the Global Drug Eluting Balloon Catheter Market in the near future. Increasing number of patients with cardiovascular ailments and surging rate of cardiology intervention procedures is driving the demand for drug eluting balloon catheter. Manufacturers are also trying to develop low-cost devices, which will further boost its adoption over the next couple of years.

    Request for a Sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=146

    As per the latest report publish by Fact.MR, the global drug eluting balloon catheter market is poised to grow reflect a staggering CAGR of 18.3% during the forecast period 2018 and 2022. At the same time, improved reimbursement support, increasing healthcare expenditure and growing geriatric population are some of the other additional factors likely to influence the growth of the market.

    Drug-eluting balloon (DEB), also known as drug-coated balloon (DCB) is one of the newest medical devices under the catheter segment.  Drug-eluting balloon catheter is used in undertaking peripheral artery procedures, particularly to reduce the rate of restenosis. A drug-eluting balloon catheter is inserted into a narrowed, unhealthy coronary or peripheral artery that slowly releases a drug to restrict further cell proliferation.

    View complete report with Table of Contents: https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market

    Drug Eluting Balloon Catheter Market in Europe to Remain Highly Attractive 

    Europe is currently the largest market for drug eluting balloon catheter and is expected to continue its dominance throughout the assessment period. The market in the region is set to reflect a robust CAGR of 20.5% during the assessment period. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) will reflect the fastest CAGR and gain 452 BPS between 2017 and 2022.

    By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.

    By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market. By 2022-end, the hospital segment is expected to reach a market valuation of over US$ 333 Mn.

    Competition Tracking

    Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corporation, Terumo Corporation, Boston Scientific Corporation, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, and Medtronic Plc. are the leading companies profiled in Fact.MR’s report.

    For any query get connect with an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=146

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    FactMR




    (EMAILWIRE.COM, January 09, 2019 ) Microbial cell banking is a cell preservation technique used to maintain cell potency, recovery and viability. Microbial cell banking has several applications in the manufacturing of biological therapeutics. In general, the number of biological therapeutics are derived from microbial cells either the natural way or through genetic modification. In Microbial Cell Banking Market, cell substrates are preserved and used to maintain the uniformity & integrity of cells. The success rate of microbial cell banking highly depends upon the type of cell medium used according to the requirements.

    Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1480

    Microbial cell banking is classified into two types: master cell banking and working cell banking. Master cell banking is defined as the process of preserving the initial clone or the preliminary cell substrates derived from the initial clone. Master cell banks are cryopreserved to control the contamination, genetic variation and degradation. Working cell banks are derived from master cell banks and are used for developing last-stage biological therapeutics. Even though working cell banks are derived from the master cell bank, there is a huge difference in culture conditions and cell culture components. In master cell banking as well as working cell banking, the maintenance of identity, purity and stability is the prime requisite for the success of microbial cell banking.

    Microbial Cell Banking Market: Drivers and Restraints

    The quality of biologics is highly depended upon the quality of cell substrates used for their development & manufacturing. Growth in the demand for high-quality cell substrates is boosting the microbial cell banking market. Moreover, raising concerns of contamination and gene variability during biopharmaceutical production processes has boosted the adoption of microbial cell banking. Furthermore, rapid advancements of microbiology has led to the incorporation of cell substrates/viable cells in the treatment of diseases. The development of microbial cell-based therapeutics has high potential in treating unmet medical needs. Whereas, increase in the demand for cell substrates for the treatment of unmet medical needs has also boosted the adoption of microbial cell banking among end users. Apart from these, the legislative structure has incorporated quality standards in developing cell-based biopharmaceuticals. It has led to increasing dependency upon microbial cell banking to ensure the quality and safety of biopharmaceuticals. Moreover, increase in the number of research activities to develop biopharmaceuticals for unmet medical needs is boosting the microbial cell banking market. All these factors act as potential drivers of the microbial cell banking market. However, rising concerns regarding contamination and complexity are hampering the growth of the microbial cell banking market.

    Request Full Report with TOC: https://www.factmr.com/report/1480/microbial-cell-banking-market

    Microbial Cell Banking Market: Overview

    The global market for microbial cell banking is expected to register a significant growth rate over the forecast period due to an increase in the demand for microbial cell banking. There is high competition in the microbial cell banking market due to the presence of a large number of market players. To sustain in competition, manufacturers mainly depend upon innovations that help improvise the existing microbial cell banking models. Increase in the adoption of microbial cell banking has replaced the traditional method of preservations. Significant demand for high-quality biopharmaceuticals is expected to boost the demand for microbial cell banking over the forecast period.

    Microbial Cell Banking Market: Regional Outlook

    Geographically, the global microbial cell banking market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to account for a major share in the global microbial cell banking market owing to increasing adoption. The microbial cell banking market in Europe is the second-largest shareholder due to an increase in the number of research initiatives among end users. The Asia Pacific excluding Japan and Latin America regions are expected to witness fast growth as compared to other regions due to increasing investments for biopharmaceutical development. Middle East & Africa is expected to account for a small market share as compared to other regions.

    Microbial Cell Banking Market: Key Players

    The global microbial cell banking market is highly fragmented owing to the presence of a large number of domestic manufacturers. Some of the key players of the global microbial cell banking market are Lonza Group Ltd.; Merck KGaA; Biovian Oy; Vibalogics GmbH; Eurofins Scientific; Luina Bio; Altogen Labs; VGXI, Inc.; ATCC and Charles River Laboratories, Inc.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    Ask an Analyst- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1480

     About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, January 09, 2019 ) Spray dispenser is also known as air neutralizer or aerosol dispenser. Mini refillable spray dispenser is creating new opportunities in the perfume and spray industry. The main advantage of this product is that it can be carried easily while traveling. Prior to the invention of mini refillable spray dispenser, the consumer has to throw the spray dispenser once it gets emptied. Mini refillable spray dispensers are useful not only for personal use, but it finds suitable applications in other end-use industries including automotive, food & beverages, pharmaceutical, and others to keep germ free environment. Mini refillable Spray dispenser can be automatic or manual. Automatic dispensers have advantages of refreshing the surrounding continuously. Overall, the outlook for the global mini refillable spray dispenser market is expected to be positive during the next decade.

    Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=1481

    Mini Refillable Spray Dispenser Market: Dynamics

    The market for mini refillable spray dispenser is gaining traction due to its unique design concept which gives customers a new experience. The growing awareness among consumers regarding health and keeping the clean & germ-free environment is expected to drive the growth of mini refillable spray dispenser market during the forecast period. The rising demand for mosquito repellants, air fresheners, and perfumes, and maintain cleaner environments, from hospitals to restaurants, also support the health of patients, customers, and even animals by keeping air fresh. Also, the use of products such as water repellant coatings, pre-wash sprays is increasing. These factors are expected to fuel the demand for global mini refillable spray dispenser market. Using mini refillable spray dispenser is one of the economical methods to keep clinics, offices, and homes fresh and hygienic. The advantage of using mini refillable spray dispenser is that it is refillable, portable and can be taken anywhere. It is expected to drive the global demand for mini refillable spray dispenser market growth during the next decade. The rising demand of mini refillable spray dispenser in personal care, cosmetic and various end-use industries such as pharmaceutical, food & beverage and others is expected to drive the global mini refillable spray dispenser market during the forecast period.  

    Request Full Report with TOC: https://www.factmr.com/report/1481/mini-refillable-spray-dispenser-market

    Mini Refillable Spray Dispenser Market: Regional Outlook

    Mini refillable spray dispenser market is expected to witness a positive outlook during the forecast period. North America and Western Europe regions are expected to drive the global mini refillable spray dispenser market during the next decade. It is attributed to the high standard of living and high disposable income of the people. Also, the awareness among the individuals regarding the cleaner environment in the regions is expected to fuel the mini refillable spray dispenser market growth. It is followed by APAC, growing urbanization in countries such as India and China boost the demand for perfumes, room fresheners and other personal care products is anticipated to drive the growth of global mini refillable spray dispenser market in the near future. The regions such as Latin America, MEA and others are expected to witness average growth in the global mini refillable spray dispenser market during the forecast period.

    Mini Refillable Spray Dispenser Market: Key Players

    Some of the global players operating in mini refillable spray dispenser market are- Guala dispensing, Midlink, Fuji sprays, Spraying Systems Co., Colep UK Ltd, Sema Sprayers Ltd., Taplast S.p.a.

    The research report presents a comprehensive assessment of the market, and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, product type, application and end use.

    Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=1481

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    Sharik
    353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, January 09, 2019 ) Adoption of cutting balloon catheter is expected to remain sluggish during the forecast period. This is primarily owing the arrival of better alternatives for undertaking minimally invasive endovascular procedures. Due to tremendous advancement in medical technology, a slew of advanced catheters have been developed to treat arterial atherosclerosis. In addition, rising prevalence of cardiovascular ailments is prompting the need for more efficient balloon catheters. Medical device manufacturers are focusing on developing multipurpose balloon catheters owing to a higher consumer preference for such devices. Factors as such are making a negative impact on the global sales of cutting balloon catheters. However, cutting balloon catheter will stay relevant to most healthcare settings as surgeons and physicians will continue to use them in various medical cardiovascular surgeries. As per the latest report published by Fact.MR, the Global Cutting Balloon Market will expand at a miniscule CAGR of 2.4% between 2017 and 2022.

    Request for a Sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=145

    A cutting balloon catheter is a medical device used in angioplasty procedures, and was invented by Barath et al. It allows percutaneous coronary interventions in arteries or veins. The device incorporates a distinctive tip with microsurgical blades, which can be activated by inflating the balloon.  Boston Scientific's Flextome is the one of the most commonly used cutting balloon catheter device.

    North America Spearheading the Global Cutting Balloon Catheter Market

    The cutting balloon catheter market in North America is expected to remain attractive in 2017 and beyond. This is owing to existence of an advanced healthcare infrastructure coupled with the rising healthcare spending in countries such as the U.S. and Canada. Meanwhile, Europe is estimated to account for more than 30% revenue share of the market by 2017-end. The market in Asia-Pacific excluding Japan (APEJ) is projected to witness the higher CAGR during the forecast period.

    On the basis of indication, the coronary artery disease cutting balloon catheter segment is projected to hold its dominant position over the assessment period. Currently, the segment accounts for close to 73% share of the market in terms of revenue. In addition, the segment is expected to reach a market valuation of over US$ 134 Mn towards the end of 2022.

    Based on end user, the hospitals segment will retain its dominance over 2022. The segment is projected to surpass a valuation of US$ 121 Mn by the end of forecast period. The segment currently accounts for nearly 67% revenue share of the global market and is expected to create absolute $ opportunity of US$ 12 Mn from 2017 to 2022.

    View complete report with Table of Contents: https://www.factmr.com/report/145/cutting-balloon-catheter-market

    Competition Tracking

    Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic Plc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Cordis Corporation, Cook Medical Inc., MicroPort Scientific Corporation, Cardionovum GmbH, Meril Life Sciences Pvt Ltd, and Hexacath are the leading market players mentioned in the Fact.MR’s report. Majority of these player are concentrating on further production innovation.

    For any query get connect with an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=145

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    FactMR




    (EMAILWIRE.COM, January 09, 2019 ) The growing prevalence of atherosclerosis is expected to be a major factor driving the growth of the Renal Artery Stenosis Treatment Market over the forecast period. The worldwide prevalence of atherosclerotic renal artery stenosis is 0.5% in the overall population, and 5-4% among patients with chronic kidney disease. Increasing peripheral atrial disease and cholesterol problems are the other factors expected to boost the demand for renal artery stenosis treatment drugs. Inactive lifestyles, unhealthy eating habits, irregular eating timings, and lack of exercise are attributed to the growing prevalence of renal artery stenosis.  

    Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1489

    Increasing hypertension problems among the general population and increasing older population are other factors expected to fuel the growth of the renal artery stenosis treatment market. Increasing diagnosis rates due to screening programs, favorable Medicare policies, increasing and healthcare expenditures are other reasons for the growth of the renal artery stenosis treatment market. The side effects associated with some renal artery stenosis treatment medications and no proper treatment available for renal artery stenosis associated with fibromuscular dysplasia are some of the factors expected to restrain the renal artery stenosis treatment market

    Renal artery stenosis is the narrowing of the renal artery that carries blood to the kidneys. The narrowing of the renal artery obstructs blood flow, resulting in renovascular hypertension, high blood pressure, and kidney damage. Atherosclerosis and fibromuscular dysplasia are the major causes of renal artery stenosis. Atherosclerosis is the most common cause of renal artery stenosis in the older age group. 90% renal artery stenosis is caused by atherosclerosis. Atherosclerosis is a disease in which the inside of the artery narrows due to plaque buildup of cholesterol and fats. Atherosclerosis is associated with the narrowing, clogging, and hardening of the renal arteries. Fibromuscular dysplasia is commonly seen in the young age group, and predominantly affects women. Fibromuscular dysplasia is a rare cause of renal artery stenosis, in which the arterial wall cells undergo abnormal growth. Chronic kidney disease, coronary artery disease, peripheral vascular disease, and stroke are the possible complications associated with renal artery stenosis. For renal artery stenosis treatment, doctors mostly prescribe medication to lower cholesterol levels and high blood pressure. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers are the most common blood pressure lowering medications used for renal artery stenosis treatment. Diuretic, beta blockers, and calcium channel blockers are other common drugs used for renal artery stenosis treatment.

    Request Full Report with TOC: https://www.factmr.com/report/1489/renal-artery-stenosis-treatment-market

    Renal Artery Stenosis Treatment Market: Drivers and Restraints

    The global market for renal artery stenosis treatment is expected to witness moderate growth over the forecast period. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers Renal Artery Stenosis Treatment are expected to contribute major revenue share in the renal artery stenosis treatment market. Among both of the indications, the atherosclerosis segment is expected to lead in the global renal artery stenosis treatment market over the forecast period. The retail pharmacies distribution channel segment in is expected to contribute a high share in the global renal artery stenosis treatment market, as it is the most accessible channel and a majority of patients are recommended for outpatient treatment.

    Renal Artery Stenosis Treatment Market: Regional Outlook

    Geographically, the global renal artery stenosis treatment market is segmented into America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global renal artery stenosis treatment market, owing to the high prevalence of atherosclerosis among the older population. Europe Renal Artery Stenosis Treatment market is expected to have the second-largest share in the global renal artery stenosis treatment market throughout the forecast period, owing to high awareness regarding health-related problems and increasing healthcare screening programs. The renal artery stenosis treatment market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to increasing healthcare expenditure and increasing healthcare facilities.  

    Renal Artery Stenosis Treatment Market: Key Players

    Examples of some of the key players operating in the global renal artery stenosis treatment market are Abbott Laborites, Pfizer Inc., Novartis AG, Merck & Company, Inc., AstraZeneca plc., Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., and others.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

    Ask Industry Expert about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=1489

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    FactMR




    (EMAILWIRE.COM, January 09, 2019 ) Major factors driving the market of uraemia treatment are increasing incidence of diabetes, high blood pressure, increasing prevalence of end-stage renal disease and increasing number of kidney transplants. Increasing healthcare expenditure, rising geriatric population and increased disposable income drive the Uraemia Treatment Market. Moreover, increasing demand for advanced dialysis machines and increased R&D activities for uraemia treatment are boosting the uraemia treatment market. In addition, the availability of favourable reimbursement policies and the rising demand for home dialysis are boosting the uraemia treatment market. However, high cost of uraemia treatment, stringent regulations and lack of awareness about kidney disease are among factors hampering the growth of the uraemia treatment market.

    Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1475

    Uraemia is a clinical syndrome associated with electrolyte, fluid, hormone imbalance and metabolic abnormalities, which develops due to the deterioration of the renal function. Uraemia occurs when the kidney is damaged. The toxins or body waste, which is normally send out through the urine, end up in the bloodstream. Uraemia is caused due to long-running health problems, such as high blood pressure and diabetes, because of infections that damage the kidney as well as severe injury. Uraemia, if not treated, can cause heart disease, anaemia and brain damage. People suffering from uraemia have proteins, creatine and other substances in the blood, which can affect all the systems of the body. Uremia is a medical emergency that usually requires urgent treatment. People suffering from uraemia need dialysis to filter the blood. In certain cases, kidney transplant is an option for treating uraemia. Uraemia patients show signs of metabolic acidosis in which the body produces excess of acid, nausea, vomiting and loss of appetite, which are some of the symptoms seen in uraemia patients. Haemodialysis and peritoneal dialysis are uraemia treatments that involve the removal of waste matter from the blood with the help of a machine. Uraemia is usually diagnosed by blood tests that check the level of creatinine.

    Uraemia Treatment Market: Segmentation

    The global uraemia treatment market can be segmented on the basis of treatment type, end user and geography.

    Based on treatment type, the global uraemia treatment market is segmented as:

    Haemodialysis:
    Peritoneal dialysis
    Based on the end user, the global uraemia treatment market is segmented as:

    Hospital
    Dialysis Facility
    Ambulatory Care Centre
    Home Care
    Uraemia Treatment Market: Overview

    The global market for uraemia treatment is expected to register significant growth over the forecast period due to increasing diabetic population. Several service providers are present in the uraemia treatment market in developed as well as developing countries.  

    Request Full Report with TOC: https://www.factmr.com/report/1475/uraemia-treatment-market

    On the basis of treatment type in uraemia treatment market, peritoneal dialysis segment dominates the uraemia treatment market owing to the advantages of peritoneal dialysis over haemodialysis, which include easy-to-use machines, negligible usage of needles and reduction in clinical visits. Increase in the number of dialysis centres across the globe is expected to fuel the uraemia treatment market during the forecast period.

    Uraemia Treatment Market: Regional Outlook

    Geographically, the global uraemia treatment market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the leading uraemia treatment market worldwide owing to the increasing incidence of diabetes and high blood pressure. The uraemia treatment market in Europe is the second largest worldwide due to an increase in the number of dialysis centres and improved healthcare infrastructure. The Asia Pacific excluding Japan and Latin America regions in uraemia treatment market are expected to witness fast growth as compared to other regions due to large patient population, increased number of end users and increased awareness about kidney-related diseases. However, Latin America and Middle East & Africa region in uraemia treatment market is expected to account for slow growth during the forecast period.

    Uraemia Treatment Market: Service Provider

    The global uraemia treatment market is highly fragmented owing to the presence of a large number of service providers. Some of the key players operating in the global uraemia treatment market are Renal Services (UK) Limited, DaVita Inc., UCI Health, U.S. Renal Care, Fresenius Medical Care, Assure Dialysis Services, Bairnsdale Regional Health Service, SYNLAB and Satellite Healthcare Inc.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    Ask Industry Expert about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=1475

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/

     


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, January 09, 2019 ) According to this study, over the next five years the Gesture Recognition and Touchless Sensing market. In particular, this report presents the global revenue market share of key companies in Gesture Recognition and Touchless Sensing.

    This report presents a comprehensive overview, market shares and growth opportunities of Gesture Recognition and Touchless Sensing market by product type, application, key companies and key regions.

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

    GestureTek (U.S.)

    Intel Corporation (U.S.)

    Microchip Technology Inc. (U.S.)

    Qualcomm Technologies, Inc. (U.S.)

    Thalmic Labs (Canada)

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Get more Information Download a Sample Copy @ https://www.reportsweb.com/inquiry&RW00012396361/sample

    This study considers the Gesture Recognition and Touchless Sensing value generated from the sales of the following segments:

    Segmentation by product type:

    Biometric Products

    Sanitary Equipment

    Segmentation by application:

    Healthcare

    Hospitality

    Consumer Electronics

    Retail Industries

    Research objectives

    To study and analyze the global Counter UAV (C-UAV) Technologies market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

    To understand the structure of Counter UAV (C-UAV) Technologies market by identifying its various subsegments.

    Focuses on the key global Counter UAV (C-UAV) Technologies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the Counter UAV (C-UAV) Technologies with respect to individual growth trends, future prospects, and their contribution to the total market.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    To project the size of Counter UAV (C-UAV) Technologies submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

    Get Exclusive Discount on Report @ https://www.reportsweb.com/inquiry&RW00012396361/discount

    Table of Contents
    1 Report Overview

    2 Global Growth Trends

    3 Market Share by Key Players

    4 Breakdown Data by Type and Application

    5 United States

    6 Europe

    7 China

    8 Japan

    9 Southeast Asia

    10 India

    11 Central & South America

    12 International Players Profiles

    12.1 Qualcomm, Inc.

    12.1.1 Qualcomm, Inc. Company Details

    12.1.2 Company Description and Business Overview

    12.1.3 Gesture Recognition and Touchless Sensing Introduction

    12.1.4 Qualcomm, Inc. Revenue in Gesture Recognition and Touchless Sensing Business (2014-2019)

    12.1.5 Qualcomm, Inc. Recent Development

    12.2 Samsung Electronics Co., Ltd.

    12.2.1 Samsung Electronics Co., Ltd. Company Details

    12.2.2 Company Description and Business Overview

    12.2.3 Gesture Recognition and Touchless Sensing Introduction

    12.2.4 Samsung Electronics Co., Ltd. Revenue in Gesture Recognition and Touchless Sensing Business (2014-2019)

    12.2.5 Samsung Electronics Co., Ltd. Recent Development

    12.3 TDK Corporation

    12.3.1 TDK Corporation Company Details

    12.3.2 Company Description and Business Overview

    12.3.3 Gesture Recognition and Touchless Sensing Introduction

    12.3.4 TDK Corporation Revenue in Gesture Recognition and Touchless Sensing Business (2014-2019)

    12.3.5 TDK Corporation Recent Development

    13 Market Forecast 2019-2025

    Place Direct Purchase order For Complete report @ https://www.reportsweb.com/inquiry&RW00012396361/buying


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, January 09, 2019 ) According to the new market research report "Weight Loss and Weight Management Market” is estimated to reach USD 245.51 Billion by 2022 from USD 175.94 Billion in 2017, at a CAGR of 6.9%."Weight Loss and Weight Management Market by Equipment (Fitness (Treadmill, Elliptical, Stair Stepper), Surgical Equipment (Biliopancreatic Diversion, Gastric Bypass)), Diet (Meal, Beverage, Supplement), and Weight Loss Services - Global Forecast to 2022"
    The growth of this market is majorly attributed to the growing rate of obesity, increasing prevalence of lifestyle diseases, and increasing number of bariatric surgeries.
    Beverages segment to dominate the market in 2017
    Based on diet, the weight loss and weight management market is segmented into meals, beverages, and supplements. In 2017, the beverages segment is expected to account for the largest share of the weight loss and weight management market. Growth in this segment is majorly driven by the growing diabetic population across the globe.
    The fitness equipment segment is projected to grow at the highest CAGR during the forecast period.
    Download Free Brochure: www.marketsandmarkets.com/pdfdownloadNew.asp?id=1152
    By equipment, the weight loss and weight management market is segmented into fitness equipment and surgical equipment. The fitness equipment segment is estimated to register the highest growth rate during the forecast period. The high growth in this segment can primarily be attributed to the continuous technological advancements in fitness equipment and growing accessibility to gyms.
    North America to dominate the weight loss and weight management market
    In 2017, North America is expected to dominate the global market primarily due to factors such as the increasing incidence of obesity and chronic diseases, rising awareness about nutrition and healthy lifestyles, and growing number of fitness centers in the region. In 2017, Europe is expected to account for the second-largest share of this market. Rising prevalence of obesity and increasing government support and initiatives to tackle obesity-related problems are the major factors supporting the growth of the weight loss and weight management market in this regional segment.
    Get Sample Pages: www.marketsandmarkets.com/requestsampleNew.asp?id=1152
    The weight loss and weight management market is highly competitive, with the presence of several small and large players. Some of the players operating in this market include Atkins Nutritionals (US), Herbalife (US), Nutrisystem (US), Ethicon (US), Covidien (US), Apollo Endosurgery (US), Brunswick (US), Amer Sports (Finland), Johnson Health Technology (Taiwan), Technogym (Italy), Weight Watchers (US), Jenny Craig (US), eDiets.com (US), VLCC Healthcare (India), Slimming World (UK), The Gold’s Gym (US), Duke Diet & Fitness Center (US), Equinox (US), Life Time Fitness (US), Fitness First Group (US), and Town Sports (US).

    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    newsletter@marketsandmarkets.com



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, January 09, 2019 ) FactMR has published a new research report titled “Global Epistaxis Market Expectations & Growth Trends Highlighted till 2026” to its online database that tries to unveil the various scenarios prevailing in the epistaxis market. This assessment delivers a smart compilation of primary and secondary data which provides a clear insight about the future plans expected to impact the Epistaxis Market. This study comprises of prominent data which makes it a beneficial source for investors, analysts and industry experts to acquire necessary knowledge associated to the fundamental market trends, opportunities and growth drivers during 2017-2026.

    Get Sample PDF Illustration Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=344

    Conditions that predispose a person to nosebleeds include dry and less humid weather conditions and increasing prevalence of hypertension. According to World Health Organization (WHO), over 12% of the deaths caused globally are due to hypertension. Incidence of nosebleeds continue to increase with the increasing cases of hypertension. Moreover, prevalence of hypertension in pregnant women leads to increasing blood flow towards the mucous membrane. Such factors continue to rev up demand for the epistaxis products in the global market.

    Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to crusting of the mucous secretion processes, which can result into cracks in the nose lining. Extreme dryness and heat in the air can result in dry nasal membrane and eliminates the amount of moisture required to be maintained in the nose. Frequent changes in the environmental conditions such as less humid weather and extremely cold winters lead to increasing instances of dry nasal membrane. Dry nasal membrane leads to increasing occurrences of nosebleeds during the hot, cold and dry weather. Increasing incidences of dry nasal membrane and abnormal nosebleeds is expected to boost demand for epistaxis products during the forecast period. 

    Manufacturers are focusing on developing epistaxis products that offer improved performance and result. Incorporation of innovation in the epistaxis products has led to more effective and advanced treatment procedures for epistaxis. Innovative treatment procedures include various surgical and non-surgical interventional procedure. Innovative treatment for nasal packing, embolization and warm water irrigation are a few non-interventional surgeries.

    Browse Market Report with TOC Here - https://www.factmr.com/report/344/epistaxis-market

    Endoscopic litigation of sphenopaletine artery, maxillary, artery litigation and nasal cauterization are the innovative treatments that include surgical intervention. Adoption of innovative surgeries are significantly changing the trends in the global epistaxis market. Moreover, manufacturers are increasingly focusing on developing epistaxis products for the treatment of patients with special medical conditions such as asthma, pregnancy, diabetes and cancer. These factors are expected to contribute towards growth of the global epistaxis market during the forecast period.

    With the growing incidences of nose cauterization among the children and adults has led to surge in demand for cauterization agents in the global market. On the basis of product type, the cauterization agents segment is expected to represent the highest revenue growth, accounting for a value of over US$ 30 Mn by the end of 2026. On the other hand, the antibiotic ointment product type segment is expected to register a significant CAGR during the forecast period.

    Based on distribution channel, the retail pharmacies segment is expected to generate significant revenues, accounting for a value of nearly US$ 20 Mn by the end of 2017. However, the specialty clinics distribution channel segment is expected to register a robust CAGR through 2026.

    By indication, the anterior segment is expected to represent a robust revenue growth, recording a value of nearly US$ 80 Mn by the end of 2026. In contrary, the posterior indication segment is expected to register a healthy CAGR throughout the forecast period.

    Competition Tracking

    Leading market players operating on the global epistaxis market include Bristol-Myers Squibb Company, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Pfizer Inc., Medline Industries, Inc., Smith & Nephew, GlaxoSmithKline PLC and Ferring B.V.

    Grab Customized Market Report from Here - https://www.factmr.com/checkout/344/S

    About FactMr

    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, January 09, 2019 ) ENT surgical devices market is expected to surpass US$ 2,500 million in 2019, according to a new study by Fact.MR. The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018. Overall growth of the ENT surgical devices market can be attributed to,

    Technological advancements enhancing ENT procedure efficiency and outcome
    Reimbursement policies in favor of ENT surgeries
    Product developments accommodating demand trend such as minimal invasion
    The medical technology industry has shifted from a traditional marketing model to a care delivery model. Following the new business approach, Tier 1 and Tier 2 players portray hegemony in the market and continue to introduce disruptive technology innovations in ENT surgical devices.

    Request a sample Report at: https://www.factmr.com/connectus/sample?flag=S&rep_id=2454

    The ENT surgical devices marketplace has the presence of a broad range of surgical instruments and equipment. According to Fact.MR valuation, ENT surgical lasers account for a leading share in the global market.

    Greater reliability of the laser treatment in ENT or otorhinolaryngology has been embraced by medical professionals as well as patients. Ranging from the treatment of snoring or nasal obstruction to cancer of ear, nose and throat, laser therapy have delivered definitive results and the account of successful outcomes is rising consistently.

    Fact.MR estimates that powered ENT surgical system will also register considerable demand in 2019. Powered ENT instruments are used in procedures such as removal of soft tissue, hard tissue and bone during surgery. On the other hand, the ENT visualization systems are growing at a faster pace and over 9% y-o-y growth is expected in 2019.

    The ENT surgical devices marketplace has witnessed introduction of a number of advanced navigation system, in particular, three-dimensional guiding system. Leading ENT surgical device manufacturers have introduced advanced navigation systems that assist ENT surgeons in easier navigation during ENT surgeries.

    Browse full report along with TOC and List of Figures at: https://www.factmr.com/report/2454/ent-surgical-devices-market

    Hospitals Held Over Half the Revenues in 2018, ENT Clinics Growing Rapidly

    Fact.MR valuation finds that the ENT surgical devices market hit US$ 2,345 million in 2018 and the growth trend will continue in 2019. Hospitals continued to capture greater market share of the ENT surgical devices market in 2018. Improved hospital infrastructure with well-equipped ENT instruments can be attributed to over half the global share of hospitals in the ENT surgical devices market.

    In consonance with the rising prevalence of ENT disorders, construction of specialized ENT clinics has increased. Fact.MR finds that ENT clinics hold the second largest revenue and will grow at a faster rate in 2019.

    Fixed ENT Surgical Devices to Hold Over 37% Revenue Share in 2019

    Based on modality, three types of devices are present – handheld, portable and fixed. Owing to the popularity of fixed devices, Fact.MR estimates that these devices will continue to account for a higher market share. On the other hand, handheld devices are estimated to account for the second largest revenue in the ENT surgical devices market and will register faster expansion in the coming years.

    According to the study, North America dominates the ENT surgical devices market and will account for over one forth revenue share in 2019. The market growth in North America is favored by favorable healthcare reimbursement coverage. In addition, presence of industry leaders in the regions contributes to the higher market revenues.

    The study finds that Europe follows North America with the second largest revenues. Europe and APEJ collectively held over half the revenues in 2018. While Europe presents an established market, improving healthcare infrastructure and economic standards in APEJ can be attributed to the growth scenario of the ENT surgical devices market in the coming years.

    The Fact.MR report tracks the ENT surgical devices market for the period 2018-2028. According to the report, the ENT surgical devices market is projected to grow at 6.4% CAGR through 2028.

    Ask Our Industry Expert about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=2454

    About Fact.MR

    Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us

    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, January 09, 2019 ) In order to study the various trends and patterns prevailing in the concerned market, FactMR has included a new report titled “Fibrosarcoma Market Inclined to Deliver Positive Growth Results until 2026” to its wide online database including upcoming trends and growth factors. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. The report studies the fibrosarcoma market worldwide, especially in North America, Europe, Southeast Asia, India and Other Regions with production, size, growth, revenue, consumption, import and export in these regions. The intelligent report also anticipates that the market would grow at a constructive CAGR until 2026.

    Get Sample PDF Illustration Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=353

    Fibrosarcoma is cancer, which is a part of larger collection of cancers known as sarcomas. Fibrosarcoma is generally treated with the help of chemotherapy. Meanwhile, some fibrosarcoma is not treatable with chemotherapy, especially in the case where cancer has spread to the parts like liver. In order to treat such type of cancers, researchers are focusing on developing targeted therapies. These targeted therapies attempt to capitalize on the biological characteristic of a cancer cell to eradicate the tumor. This is the factor that will make targeted therapy more effective than the traditional treatments. There are two important reasons for the development of targeted therapy. One is that it targets only cancer cells and kills it, while normal cells can spread. Second is that it provides effective treatment with minimum side-effects. Pharmaceutical companies are also focusing on research and development of drugs that can be effective in the treatment of fibrosarcoma and other types of sarcomas.

    As per the new report by FactMR, the global market for fibrosarcoma is likely to witness steady growth between 2017 and 2026. The market is estimated to reach US$ 442.4 million revenue by 2026 end. Owing to the increasing prevalence of cancer, the use of cancer treatment drugs along with the radiotherapy and chemotherapy is witnessing a significant growth. However, increasing use of radiotherapy to treat various cancers is resulting in the fibrosarcoma. This is leading to the growth in the research activities to find out an effective way to treat cancer.

    Among various treatment types such as radiation therapy, surgery, and others, chemotherapy is likely to emerge as the highly preferred treatment for fibrosarcoma. Chemotherapy is estimated to surpass US$ 100 million by 2026 end. A chemotherapy is done before surgery in case if the cancer is large but has not spread. This helps in reducing fibrosarcoma and also helps in avoiding much surgery.

    Browse Complete Report Here - https://www.factmr.com/report/353/fibrosarcoma-market

    Hospitals are likely to witness the highest growth between 2017 and 2026.  Hospitals are estimated to gain nearly two-fifth of the revenue share by 2017 end. Hospitals are also estimated to create an incremental opportunity of nearly US$ 100 million between 2017 and 2026. Increasing investment by governments in various countries towards the development of healthcare infrastructure is contributing towards the significant growth of the hospitals with technically advanced treatments.

    Hospital pharmacy is likely to be one of the largest distribution channels in the global fibrosarcoma market during 2017-2026. Hospital pharmacy is projected to bring in nearly US$ 200 million revenue towards 2026 end. Hospital pharmacy in many countries is emerging as the biggest distributors of the drugs used in treating cancer. Moreover, availability of various drugs and government support are also resulting in the growth of the hospital pharmacy as a distribution channel. 

    Competition Tracking

    The report offers information on the key companies that are likely to play an active role in the expansion of global fibrosarcoma market through 2026, which include Cadila Pharmaceuticals Limited, Celon Laboratories Limited, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Limited, Sun Pharmaceutical Industries Limited, Novartis AG, Baxter International Inc., Eli Lilly and Company, Pfizer Inc., and Johnson & Johnson.

    To Buy this Report, Click Here - https://www.factmr.com/checkout/353/S

    About FactMr

    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, January 09, 2019 ) According to research report the global contrast media market is expected to reach USD 5.53 Billion by 2022 from an estimated USD 4.57 Billion in 2017, growing at a CAGR of 3.9% during the forecast period. Growth in the contrast media market can primarily be attributed to factors such as increasing number of approvals for contrast agents and growing number of public & private diagnostic centers. The increasing number of research and funding activities for research of contrast agents and their applications provides immense opportunities for players in the contrast media market
    The key players in this market are continuously striving to gain product approvals to secure larger shares and expand their existing product portfolios. The overall market was dominated by Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), Bracco Imaging S.p.A (Italy), Lantheus Medical Imaging (U.S.), nanoPET Pharma GmbH (Germany), CMC Contrast AB (Sweden), Daiichi Sankyo (Japan), and Subhra Pharma Private Limited (India).
    Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
    Bayer HealthCare (Germany) was the leading player in the contrast media/contrast agents market with a share of ~24% in 2015. The company continuously strives to strengthen its market position in various geographies by focusing on getting approvals for contrast media products across the world. Gadovist injection, a gadolinium-based contrast agent by Bayer, has received FDA approval in the U.S. and Japan. Gadovist is the first FDA-approved contrast agent for pediatric patients less than 2 years of age, including term neonates. The company’s major share in the market can be attributed to its broad product portfolio, several years of experience, extensive distribution channel, and various growth strategies, such as product approvals, collaborations, and expansions. The company focuses on developing innovative healthcare products with a positive cost-benefit ratio.
    Bayer HealthCare invested 5.8%, 5.5%, and 5.5% of its total healthcare revenue in 2013, 2014, and 2015, respectively, in R&D activities. The company has gained a major share in the contrast media/contrast agents market on account of its comprehensive product portfolio, wide geographical reach; focus on organic growth strategies, as well as constant focus on research and developmental activities.
    GE Healthcare (U.S.) held the second-largest share of ~21% in the contrast media/contrast agents market in 2015. The firm has a strong customer base in approximately 175 countries, primarily operating in North America, Europe, the Pacific Basin, the Americas, and the Middle East & Africa. Some subsidiaries of the firm include GE Healthcare USA Holdings, Inc., GE Healthcare Ltd. (Japan), GE Healthcare Biosciences AB (U.S.), and GE Healthcare AS (Norway). GE Healthcare received the Norwegian Medicines Agencys (NOMA) approval for SONAZOID, a contrast agent used in ultrasound imaging of focal liver lesions. However, with competition in the market and the entry of new companies, it is necessary for GE to innovate continuously in order to keep its technology at the forefront and maintain its position in the market. The company’s robust product portfolio, large number of subsidiaries, focus on customers, and new product launches have also helped expand its share in the contrast media/contrast agents market.
    Sample of the report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
    Players operating in the contrast media/contrast agents market adopted strategies such as product approvals, which was the most-preferred strategy (43.6% of the total strategic developments in the market during 2013 to 2016). The key players that have adopted this strategy include Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), Bracco Imaging S.p.A (Italy), Spago Nanomedicine AB (Sweden), and CMC Contrast AB (Sweden).


    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    newsletter@marketsandmarkets.com



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

older | 1 | .... | 1133 | 1134 | (Page 1135) | 1136 | 1137 | .... | 1146 | newer